American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
52.12
+0.25 (0.48%)
Mar 5, 2026, 4:00 PM EST - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for American Healthcare REIT stock have an average target of 52.27, with a low estimate of 37 and a high estimate of 60. The average target predicts an increase of 0.29% from the current stock price of 52.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $52 → $55 | Hold | Maintains | $52 → $55 | +5.53% | Mar 2, 2026 |
| Citizens | Citizens | Buy Reiterates $60 | Buy | Reiterates | $60 | +15.12% | Feb 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $55 | Buy | Initiates | $55 | +5.53% | Jan 29, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $53 → $52 | Strong Buy | Maintains | $53 → $52 | -0.23% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $46 → $53 | Strong Buy | Maintains | $46 → $53 | +1.69% | Nov 26, 2025 |
Financial Forecast
Revenue This Year
2.66B
from 2.26B
Increased by 17.93%
Revenue Next Year
2.96B
from 2.66B
Increased by 10.97%
EPS This Year
0.73
from 0.42
Increased by 74.80%
EPS Next Year
1.20
from 0.73
Increased by 63.81%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.7B | 3.9B | |||
| Avg | 2.7B | 3.0B | |||
| Low | 2.3B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.3% | 47.8% | |||
| Avg | 17.9% | 11.0% | |||
| Low | 0.0% | -11.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.83 | 2.42 | |
| Avg | 0.73 | 1.20 | |
| Low | 0.57 | 0.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 98.3% | 230.3% | |
| Avg | 74.8% | 63.8% | |
| Low | 35.9% | -6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.